Cargando…
A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency
Steroid 21-hydroxylase deficiency accounts for about 95% of cases of congenital adrenal hyperplasia (CAH). Newborns are currently being screened for the classical forms of this disease throughout the United States and in 12 other countries. As such, it seems important to develop the best practice gu...
Autores principales: | Speiser, Phyllis W., Azziz, Ricardo, Baskin, Laurence S., Ghizzoni, Lucia, Hensle, Terry W., Merke, Deborah P., Meyer-Bahlburg, Heino F. L., Miller, Walter L., Montori, Victor M., Oberfield, Sharon E., Ritzen, Martin, White, Perrin C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963799/ https://www.ncbi.nlm.nih.gov/pubmed/20981249 http://dx.doi.org/10.1155/2010/494173 |
Ejemplares similares
-
Congenital Adrenal Hyperplasia
por: Speiser, Phyllis W.
Publicado: (2015) -
Emerging medical therapies for congenital adrenal hyperplasia
por: Speiser, Phyllis W.
Publicado: (2019) -
Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras
por: Lao, Qizong, et al.
Publicado: (2021) -
What explains discrepant gender identity outcome in 46,XX individuals with 11-hydroxylase deficiency?
por: Meyer-Bahlburg, Heino F. L.
Publicado: (2007) -
Management challenges and therapeutic advances in congenital adrenal hyperplasia
por: Mallappa, Ashwini, et al.
Publicado: (2022)